Cargando…
Intratumor childhood vaccine-specific CD4(+) T-cell recall coordinates antitumor CD8(+) T cells and eosinophils
BACKGROUND: Antitumor mechanisms of CD4(+) T cells remain crudely defined, and means to effectively harness CD4(+) T-cell help for cancer immunotherapy are lacking. Pre-existing memory CD4(+) T cells hold potential to be leveraged for this purpose. Moreover, the role of pre-existing immunity in viro...
Autores principales: | Brown, Michael C, Beasley, Georgia M, McKay, Zachary P, Yang, Yuanfan, Desjardins, Annick, Randazzo, Dina M, Landi, Daniel, Ashley, David M, Bigner, Darell D, Nair, Smita K, Gromeier, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124325/ https://www.ncbi.nlm.nih.gov/pubmed/37072349 http://dx.doi.org/10.1136/jitc-2022-006463 |
Ejemplares similares
-
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma
por: Beasley, Georgia M, et al.
Publicado: (2021) -
Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanoma
por: Beasley, Georgia M, et al.
Publicado: (2022) -
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control
por: Rodriguez-Ruiz, Maria E, et al.
Publicado: (2023) -
Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model
por: Shankara Narayanan, Jayanth S, et al.
Publicado: (2023) -
Intratumoral administration of CD1c (BDCA-1)(+) and CD141 (BDCA-3)(+) myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial
por: Schwarze, Julia Katharina, et al.
Publicado: (2022)